BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3596075)

  • 1. Mucus glycoprotein content of human cholesterol gallstones.
    Pearson JP; Foster SN
    Digestion; 1987; 36(3):132-40. PubMed ID: 3596075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative and qualitative comparison of gall bladder mucus glycoprotein from patients with and without gall stones.
    Harvey PR; Rupar CA; Gallinger S; Petrunka CN; Strasberg SM
    Gut; 1986 Apr; 27(4):374-81. PubMed ID: 3957108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of gallbladder mucus hypersecretion in the evolution of cholesterol gallstones.
    Lee SP; LaMont JT; Carey MC
    J Clin Invest; 1981 Jun; 67(6):1712-23. PubMed ID: 7240416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucin glycoprotein content of human pigment gallstones.
    LaMont JT; Ventola AS; Trotman BW; Soloway RD
    Hepatology; 1983; 3(3):377-82. PubMed ID: 6840683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of hepatic bile mucus glycoprotein in development of intrahepatic gallstones.
    Akaishi S; Yoshihara S; Sasaki M; Konn M
    J Gastroenterol; 1995 Dec; 30(6):758-63. PubMed ID: 8963394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ground squirrel model for cholelithiasis: role of epithelial glycoproteins.
    MacPherson BR; Pemsingh RS
    Microsc Res Tech; 1997 Oct; 39(1):39-55. PubMed ID: 9329018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total biliary protein, mucus glycoproteins, cyclic-AMP, and apolipoproteins in the gallbladder bile of patients with cholesterol stones and stone-free controls.
    Swobodnik W; Wenk H; Janowitz P; Hagert N; Kratzer W; Berghold J; Zhang Y; Bittner R; Schusdziarra V; Ott R
    Scand J Gastroenterol; 1991 Jul; 26(7):771-8. PubMed ID: 1654593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro nucleation factors--mucus glycoprotein and proteins: changes and mechanisms in the process of sludge and gallstone formation].
    Zhang X
    Zhonghua Wai Ke Za Zhi; 1991 Feb; 29(2):121-5, 143-4. PubMed ID: 1864186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the structure of the mucous gel on the mucosal surface of the stomach in association with peptic ulcer disease.
    Younan F; Pearson J; Allen A; Venables C
    Gastroenterology; 1982 May; 82(5 Pt 1):827-31. PubMed ID: 7060905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How often are Ghananian gallbladder stones cholesterol-rich.
    Darko R; Archampong EQ; Qureshi Y; Muphy GM; Dowling RH
    West Afr J Med; 2000; 19(1):64-70. PubMed ID: 10821090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric mucus: isolation and polymeric structure of the undegraded glycoprotein: its breakdown by pepsin.
    Pearson J; Allen A; Venables C
    Gastroenterology; 1980 Apr; 78(4):709-15. PubMed ID: 6766422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physico-chemical characteristics of mucus glycoproteins and lipids of the human oral mucosal mucus coat in relation to caries susceptibility.
    Slomiany BL; Murty VL; Mandel ID; Zalesna G; Slomiany A
    Arch Oral Biol; 1989; 34(4):229-37. PubMed ID: 2597017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity.
    Shaffer EA; Small DM
    J Clin Invest; 1977 May; 59(5):828-40. PubMed ID: 856870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypersecretion of mucus glycoprotein by the gallbladder epithelium in experimental cholelithiasis.
    Lee SP
    J Pathol; 1981 Jul; 134(3):199-207. PubMed ID: 6790685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of gallbladder mucin-bilirubin complex in human cholesterol gallstone matrix. Effects of reducing agents on in vitro dissolution of matrix and intact gallstones.
    Smith BF; LaMont JT
    J Clin Invest; 1985 Aug; 76(2):439-45. PubMed ID: 4031059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of a human biliary glycoprotein inhibitor of cholesterol crystallization.
    Ohya T; Schwarzendrube J; Busch N; Gresky S; Chandler K; Takabayashi A; Igimi H; Egami K; Holzbach RT
    Gastroenterology; 1993 Feb; 104(2):527-38. PubMed ID: 8425696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation and a thickened mucus layer in mice with cholesterol gallstones.
    Rege RV; Prystowsky JB
    J Surg Res; 1998 Jan; 74(1):81-5. PubMed ID: 9536979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human gall bladder mucus synthesis in patients undergoing cholecystectomy.
    Rhodes M; Allen A; Dowling RH; Murphy G; Lennard TW
    Gut; 1992 Aug; 33(8):1113-7. PubMed ID: 1398238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of human middle ear mucus glycoprotein in chronic secretory otitis media (CSOM).
    FitzGerald JE; Green GG; Stafford FW; Birchall JP; Pearson JP
    Clin Chim Acta; 1987 Nov; 169(2-3):281-97. PubMed ID: 3427782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vesicular and pronuclear glycoproteins in the pathogenesis of cholesterol lithiasis].
    Jirsa M; Smíd F; Marecek Z
    Cas Lek Cesk; 1998 Jan; 137(2):48-51. PubMed ID: 9511266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.